Stabilisation Notice
8th Oct 21
Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.
Heimstaden AB (publ)
Pre-stabilisation Period Announcement
J.P. Morgan AG, (contact: Marc Lewell +44 20 7134 2468) hereby gives notice, as Stabilisation Coordinator, that the Stabilising Manager(s) named below may stabilise the offer of the following securities in accordance with Commission Delegated Regulation EU/xxx/2016 under the Market Abuse Regulation (EU/596/2016).
| The securities: | |
| Issuer: | Heimstaden AB (publ) |
| Guarantor (if any): | N/A |
| Aggregate nominal amount: | EUR 300mm (exp) |
| Description: | EUR Perpetual-Non-Call-5.25-year FXD Unsecured Subordinated NotesListing: Nasdaq Stockholm |
| Offer price: | TBC |
| Other offer terms: | Denoms: EUR 100,000 x EUR 100,000 |
| Stabilisation: | |
| Stabilisation Manager(s): | J.P. Morgan AG (Stabilisation coordinator)Arctic Securities (Stabilisation Manager(s))Citigroup (Stabilisation Manager(s))Nordea (Stabilisation Manager(s))Swedbank (Stabilisation Manager(s)) |
| Stabilisation period expected to start on: | 8th Oct 21 |
| Stabilisation period expected to end no later than: | 8th Nov 21 |
| Existence, maximum size and conditions of use of over‑allotment facility: | The Stabilisation Manager(s) may over-allot the securities in an amount not exceeding 5% of the aggregate nominal amount stated above. |
| Stabilisation trading venue: | Over the counter, TBC |
In connection with the offer of the above securities, the Stabilising Manager(s), or persons acting on behalf of the Stabilising Manager(s) may over-allot the securities, provided that the aggregate principal amount of the securities allotted does not exceed 105 percent of the aggregate principal amount of the securities, or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, stabilisation may not necessarily occur and any stabilisation action, if begun, may cease at any time, but it must end no later than the earlier of 30 days after the issue date of the securities and 60 days after the date of allotment of the securities.
This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.
This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within Article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.
In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State that has implemented Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the "Prospectus Directive") before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Prospectus Directive (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Directive), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Directive (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that in that Member State
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.